Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the final specifications prior to release.
Inspection Record
Pacific Healthcare, Inc. dba B & B Pharmacy — FDA 483 Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Batch production and control records do not include complete information relating to the production and control of each batch.
Protective apparel is not worn as necessary to protect drug products from contamination.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed.
Aseptic processing areas are deficient in that ceilings are not smooth and/or hard surfaces that are easily cleanable.
There is no written testing program designed to assess the stability characteristics of drug products.
Washing and toilet facilities lack hot and cold water, soap or detergent, and air driers or single-service towels.
Routine calibration of mechanical and electronic equipment is not performed according to a written program designed to assure proper performance.
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use.
About this record
Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
